Hey Hylander, I am surprised. I don’t think it’s for some nefarious reason. It is disappointing, because the languishing share price has been very harmful to investors especially with the outstanding share count increasing. We know they’re on the cusp of a few achievements so there must be a plan.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links